drug
batoclimab
Phase 2updated 5mo agoby $IMVT Immunovant, Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying batoclimab
- phase3Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
- phase2To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
- phase3Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
- phase3Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
- phase2A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease
- phase2An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- phase3Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
News(1)
- Immunovant ditches lupus for multi-hyphenate inflammatory drug after mid-stage missAfter imeroprubart failed to demonstrate sufficient efficacy in lupus during a Phase 2b trial, Immunovant is moving on from the indication and looking to other high priority programs for the drug i…biospace · 11d ago
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that